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Background: Wnt/β-catenin signaling has been suggested to regulate proximal-distal determination of embryonic
lung epithelium based upon genetically modified mouse models. The previously identified and characterized small
molecule inhibitor IQ1 can pharmacologically decrease the interaction between β-catenin and its transcriptional
coactivator p300, thereby enhancing the β-catenin/CBP interaction. Inhibition of the β-catenin/p300 interaction by
IQ1 blocks the differentiation of embryonic stem cells and epicardial progenitor cells; however, whether differential
coactivator usage by β-catenin plays a role in proximal-distal determination of lung epithelium is unknown.
Methods: We examined the effects of inhibiting the β-catenin/p300 interaction with IQ1 on lung branching
morphogenesis in mouse embryos in utero and mouse embryonic lung organ culture ex vivo. The phenotype of
IQ1 treated lungs was analyzed by epithelial staining, histology, quantitative PCR and in situ hybridization.
Results: Inhibition of the β-catenin/p300 interaction by IQ1 disrupted the distal branching of mouse lung
epithelium both in utero and ex vivo. IQ1 proximalized lung epithelium with decreased expression of the genes
Bmp4 and Fgf10, hallmarks of distal lung determination, and increased expression of the proximal genes Sox2 and
Scgb1a1 (CC10) as shown by quantitative PCR and in situ hybridization. The disruption of branching was reversible
ex vivo as branching was reinitiated after removal of IQ1 from the media.
Conclusions: The results demonstrate that the β-catenin/p300 interaction plays a critical role in proximal-distal
determination of the epithelium in mouse lung branching morphogenesis and β-catenin/p300 inhibition
pharmacologically proximalizes lung epithelium.
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The ability to regulate proliferation and differentiation
of the lung has important consequences in regards to
both premature birth and bronchopulmonary dysplasia [1]
and diseases of the adult lung i.e. idiopathic pulmonary
fibrosis [2]. Furthermore, within the context of regen-
erative medicine, the ability to control lung develop-
ment may replace conventional lung transplantation,
which has inevitable problems associated with both a
shortage of suitable donors and immunogenicity leading
to the requirement for long term immunosuppression and* Correspondence: kahnm@usc.edu
1Department of Biochemistry and Molecular Biology, Keck School of
Medicine, University of Southern California, 1450 Biggy Street, Los Angeles,
CA 90033, USA
2Center for Molecular Pathways and Drug Discovery, Keck School of
Medicine, University of Southern California, 1450 Biggy Street, Los Angeles,
CA 90033, USA
Full list of author information is available at the end of the article
© 2014 Sasaki and Kahn; licensee Springer. This
Attribution License (http://creativecommons.or
in any medium, provided the original work is pfibrotic complications [3]. Regeneration is in essence a
recapitulation of development. Therefore, understanding
the signaling pathways and decision points that control
lung development is a critical goal. Lung development in-
volves branching morphogenesis. The primordial epithelial
tube undergoes repetitive branching at distal tips resulting
in a tree-like structure. Lung branching morphogenesis is
regulated by multiple signaling pathways including the FGF
pathway [4] and the Wnt signaling pathway [5]. β-catenin
is the central signaling mediator of canonical Wnt sig-
naling. Therefore, β-catenin has repeatedly been genet-
ically deleted for loss-of-function analysis or stabilized
for gain-of-function analysis in mice to study Wnt
signaling. During lung development, tissue-specific
deletion of β-catenin in the epithelium was found to
proximalize the epithelium by expanding the proximal
airway and inhibiting distal airway growth [6]. Basedis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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proximal-distal determination of the epithelium during
lung morphogenesis. However, beyond its role as a
transcriptional activator of Wnt signaling, β-catenin is also
an important protein component of adherens junction,
which is critically responsible for epithelial cell-cell adhe-
sion. Thus, genetic deletion of β-catenin in mice results in
both disruption in cell-cell adhesion and the transcrip-
tional role of β-catenin, making analysis of the phenotype
complex [5].
Chemical genetic approaches offer a complementary
method to genetic manipulation, to selectively modulate
the transcriptional role of β-catenin. To activate transcrip-
tion, β-catenin must translocate to the nucleus to interact
with transcription factors e.g. members of the TCF/LEF in
canonical Wnt signaling as well as various transcriptional
co-activators. We have identified and characterized a
number of small molecules that specifically inhibit the
protein-protein interaction between β-catenin and either of
its two Kat3 coactivators i.e. Creb binding protein (CBP) or
p300. Specifically inhibiting either the β-catenin/CBP
or the β-catenin/p300 interaction does not disturb
other protein-protein interactions involving β-catenin,
including the β-catenin/E-Cadherin interaction that is
critically responsible for epithelial cell-cell adhesion.
Therefore, specific well-characterized small molecule
pharmacologic tools provide an advantage for loss-of-
function analysis of multifunctional proteins like β-catenin.
An additional potential advantage of utilizing a pharmaco-
logic approach is the ability to temporally utilize small
molecule pharmacologic agents to manipulate cell prolif-
eration and differentiation for the purpose of regenerative
medicine. IQ1 (C21H22N4O2, molecular weight 362.42)
and ICG-001 (C33H32N4O4, molecular weight 548.63) are
specific inhibitors of the interaction between β-catenin and
the transcriptional coactivators p300 and CBP respectively.
IQ1 inhibits the interaction between β-catenin and p300
indirectly via targeting the PR72/130 subunit of PP2A
and thereby blocking PP2A/Nkd complex formation [7].
On the other hand, ICG-001 directly inhibits the inter-
action between β-catenin and CBP via binding to the
amino terminus of CBP [8]. Using these small mole-
cules, we have previously demonstrated the distinct
roles that the two coactivators p300 and CBP in β-catenin
dependent transcriptional gene regulation, despite their
high degree of identity and even higher homology.
Inhibition of the β-catenin/p300 interaction by IQ1
prevented the differentiation of embryonic stem cells
[7], whereas inhibition of β-catenin/CBP interaction
enhanced the differentiation of neural progenitor cells [9]
and human embryonic stem cells (hES cells) [10]. However,
the role of β-catenin differential coactivator utilization
in lung development and branching morphogenesis is
unknown.To investigate the role of β-catenin differential coactivator
utilization in murine lung development and branching mor-
phogenesis, we treated mouse embryonic lungs with IQ1 in
utero and ex vivo to selectively inhibit the β-catenin/p300
interaction and analyzed the phenotype by epithelial stain-
ing, histology, quantitative PCR and in situ hybridization.
Methods
Compounds
IQ1 and ICG-001 were synthesized in our laboratory
as previously described [7,11]. IQ1 and ICG-001 were
dissolved in dimethyl sulfoxide (DMSO) to prepare 100 mM
or 500 mM stock solutions. Equal volumes of DMSO
were used for controls.
Mice
TOPGAL mice were obtained from The Jackson Laboratory.
Vaginal plug at noon was considered as day 0.5 of preg-
nancy (E0.5). For administration of IQ1 or ICG-001 to
embryos in utero, timed pregnant mice were fed IQ1
(72 or 144 mg/kg/day) or ICG-001 (220 mg/kg/day)
mixed in peanut butter in addition to their regular diet.
The animal study protocol was approved by the IACUC at
the University of Southern California.
Whole mount NBT/BCIP and β-galactosidase staining
Lung samples were fixed in 4% paraformaldehyde for
1 hour to overnight and washed in phosphate buffered
saline (PBS). The lungs were incubated in a solution of
NBT/BCIP Ready-to-Use Tablets (Roche Applied Science)
according to the manufacturer’s directions. After develop-
ment of color, excess staining was removed by dehydration
and rehydration through a series of methanol washes.
The stained lungs were cleared in graded steps with
glycerol before photographing. Branching tips of the
stained lungs were counted under a bright-field stereo-
microscope. For histological analysis, the stained lungs
were re-fixed in 4% paraformaldehyde, embedded in
paraffin, sectioned and counterstained with Nuclear Fast
Red (Electron Microscopy Sciences). For β-galactosidase
staining, lungs were dissected, fixed in 0.5% glutaralde-
hyde with 2 mM of magnesium chloride and stained as
described previously. The images were captured using an
AxioImager Z1 and AxioVision digital image processing
software (Carl Zeiss) or SZX7 stereomicroscope and infin-
ity2 imaging system (Olympus).
Lung organ culture
Lungs were dissected from mouse embryos in cold sterile
Hanks’ Balanced Salt Solution under a stereomicroscope.
The lungs were randomized by size and obvious outliers
were excluded. The lungs were placed on a polycarbonate
membrane filter (Whatman) floating on 1 ml of serum-free
BGJb medium (Invitrogen) with penicillin/streptomycin in
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The lung explants were positioned at the gas–liquid
interface on the membrane filters. The Cultures were
kept at 37°C in 5% CO2 and media was changed daily.
Quantitative PCR (qPCR)
The lung explants were homogenized with TRIzol® reagent
(Invitrogen) by passing through a 25-gage needle and total
RNA was isolated according to the manufacturer’s instruc-
tions. The concentration of total RNA was measured using
a NanoDrop® spectrophotometer and reverse transcrip-
tion was performed with an iScript cDNA Synthesis Kit
(Bio-Rad). Quantitative PCR amplification was performed
using SYBR Green PCR master mix reagent (BioRad) and
a MyiQ thermal cycler (BioRad) with the following gene-
specific primers: mouse Bmp4 (CGTTACCTCAAGGGAG
TCGAGATTG, TCTTATTCTTCTTCCTGGACCGCTG),
mouse Fgf10 (TGCACATACATGAGCCCTTTGT, TTTG
CTCAGGTTAAGCCCCAG), mouse Nkx2-1 (AAATTTG
GGGGTCTTTCTGG, AGAGTGCATCCACAGGGAAG),
mouse Shh (ACTCACCCCCAATTACAACCC, TGCTCC
CGTGTTTTCCTCA), mouse Scgb1a1 (CAGCTGAAGA
GACTGGTGGAT, TGTTAGATTTTCTCCGTGAGCTT).
Melt curve analysis and gel electrophoresis were used to
examine the specificity of amplified products. Data were
normalized to the reference gene, mouse Gapdh. Relative
expression levels were calculated using the 2^-ddCt
method. Data are presented as mean ± SD. Differences in
means between two experimental groups were analyzed
using two-sample, two-tailed Student’s t-test. p < 0.05 was
considered significant.
Whole mount in situ hybridization
The lung explants were fixed in 4% paraformaldehyde for
4 hours to overnight, stored in 100% methanol at −20°C,
bleached in 3% hydrogen peroxide in methanol, rehydrated
and subsequently underwent in situ hybridization as previ-
ously described. Digoxigenin-labeled anti-sense RNA probes
were synthesized from subcloned mouse gene templates
using DIG RNA Labeling Kit (Roche Applied Science).
Hybridization was colorized with ALP conjugated anti-
DIG antibody (Roche Applied Science) and NBT/BCIP
Ready-to-Use Tablets (Roche Applied Science). Experiments
were independently repeated at least three times. The
plasmids including cDNA of mouse Nkx2-1 and Bmp4
were generously provided by Dr. Changgong Li.
Histology and immunohistochemistry
Lung samples were fixed in 4% paraformaldehyde overnight,
embedded in OCTcompound or paraffin and sectioned. For
immunohistochemistry, the sections were blocked in 1%
bovine serum albumin (BSA) (Jackson ImmunoResearch)
and incubated with primary antibodies. The antibodies used
were FITC mouse anti-β-catenin (1:400, BD TransductionLaboratories) and anti-α-SMA (1:200, Sigma). For whole
mount PECAM-1 staining, fixed lungs were dehydrated
in methanol, bleached in 3% hydrogen peroxide in in
methanol, rehydrated, blocked in 1% BSA, incubated
with anti-PECAM-1 antibody (1:200, Santa Cruz, sc-1506)
overnight at 4°C, washed in PBS, incubated with HRP-
conjugated anti-goat IgG (Santa Cruz) and colorized
with diaminobenzidine (DAB) substrate (Sigma).
Results
Alkaline phosphatase activity marks murine lung
epithelium during branching morphogenesis
Wnt signaling apparently plays a critical role during lung
branching morphogenesis. We found that murine em-
bryonic lung expresses endogenous alkaline phosphat-
ase (ALP) activity in the epithelium. The epithelium can
be selectively stained utilizing the endogenous ALP activ-
ity with the chromogenic substrate, nitro-blue tetrazolium
chloride and 5-bromo-4-chloro-3′-indolyphosphate
p-toluidine salt (NBT/BCIP). We therefore sought to
utilize NBT/BCIP to visualize epithelial branching mor-
phogenesis in whole mount mouse lung. In the event,
we stained mouse lung at four different embryonic stages
from E11.5 to E14.5 with NBT/BCIP. We observed
blue-purple staining specifically visualizing lung epi-
thelial structures during branching morphogenesis at
all four time points (Figure 1A). Next, we sectioned the
stained lungs for histological analysis and confirmed
that the blue-purple staining was localized on the apical
surface of the lung epithelium and not in the mesenchyme
(Figure 1B and 1C). These results suggest that endogenous
ALP activity is a specific marker for embryonic mouse lung
epithelium and NBT/BCIP, chromogenic substrate of ALP,
can be used to visualize the epithelial branching structure
in whole mount mouse lung using bright-field microscopy.
The β-catenin/p300 interaction during lung branching
morphogenesis
To investigate the role of differential β-catenin coactivator
usage during lung branching morphogenesis, we used
the coactivator selective small molecule inhibitors of the
β-catenin/p300 [7] and β-catenin/CBP [8] interaction
that we previously identified and have utilized extensively
[2,7,9,12]. To inhibit the β-catenin/p300 interaction during
lung morphogenesis, we treated E12.5 mouse embryos with
IQ1 in utero for two days via oral administration of IQ1 to
their pregnant mothers. In the embryonic mice at day
E14.5, we found that the inhibition of the β-catenin/p300
interaction disrupted lung branching morphogenesis. IQ1
decreased the size of the lung and dramatically decreased
the number of branching tips (Figure 2A). Despite the
branching inhibition at the distal tips, IQ1 caused an
elongation of the proximal airway compared to the control
lung at E14.5 (Figure 2A). This elongation of the proximal
Figure 1 Alkaline phosphatase (ALP) activity marks epithelial branching structures in embryonic mouse lung. (A) Mouse embryonic
lungs from four different embryonic stages i.e. E11.5, E12.5, E13.5 and E14.5 were stained with ALP substrate NBT/BCIP. Endogenous ALP activity
in blue-purple visualizes epithelial branching morphogenesis in the whole-mount lungs. (B) Histology of the stained E13.5 lung shows the specific
ALP activity around the airway cavities (*), but not in the mesenchyme. (C) Higher magnification shows that the ALP activity is specific to the
apical surface of the lung epithelial cells (arrows).
Figure 2 Inhibition of the β-catenin/p300 interaction disrupts branching morphogenesis in mouse lung. (A) Lungs from embryonic mice
treated with the β-catenin/p300 inhibiter IQ1 (right) or DMSO control (left) in utero. Pregnant mice received IQ1 (72 mg/kg/day) orally to
expose the embryos to IQ1 in utero from E12.5 for 2 days (E12.5 + 2). The lungs of the embryos were dissected and the epithelium was stained with
the ALP substrate NBT/BCIP. IQ1 decreased the size of the lung but elongated the airways. (B) Pregnant mice received IQ1 (72 mg/kg/day for low dose,
144 mg/kg/day for high dose) or ICG-001 (220 mg/kg/day) orally to expose the embryos in utero from E9.5 for 3 days (E9.5 + 3). IQ1 inhibited lung branching
morphogenesis but ICG-001 did not. (C) H-E staining shows that IQ1 dilated the airways and decreased the density of mesenchymal cells. (D) E12.5 mouse
embryonic lungs were cultured with either DMSO, IQ1 (10 μM) or ICG-001 (10 μM) for 24 hours and stained with ALP substrate NBT/BCIP. The arrows
indicate new distal tips in DMSO and ICG-001 treated explants. IQ1 disrupted branching morphogenesis ex vivo. (E) IQ1 significantly decreased the number
of the distal tips after 24 hour culture of E12.5 lungs. Data are mean ± SD from five lungs per group. *p< 0.025 vs. control by t-test.
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Figure 3 Histological analyses of IQ1 treated lungs. (A) TOPGAL,
the Wnt signaling reporter mouse shows activation of β-catenin/LEF/
TCF reporter by expression of β-galactosidase. E12.5 lung explants of
TOPGAL mouse were treated with either DMSO (control), IQ1 (10 μM)
or ICG-001 (10 μM) for 48 hours. β-galactosidase (blue) activity is
observed in the bronchial epithelium of the proximal airway (arrows).
IQ1 did not decrease β-galactosidase activity, whereas ICG-001, a
known CBP/catenin antagonist, decreased β-galactosidase activity in
the proximal airway. (B) Immunohistochemistry shows localization of
β-catenin at the cell membrane of epithelial cell (arrows) and
mesenchymal cells. (C) Whole mount PECAM-1 staining (brown)
shows capillaries around the distal tips. Four days of IQ1 treatment in
utero did not significantly disrupt formation of capillaries as judged by
PECAM staining.
Sasaki and Kahn Translational Respiratory Medicine 2014, 2:8 Page 5 of 10
http://www.transrespmed.com/content/2/1/8airways suggests that the impact of IQ1 is not due simply
to growth inhibition. IQ1 also inhibited branching with
3 day treatment initiating at E9.9; however, ICG-001
did not affect branching in utero (Figure 2B). Further,
we observed that IQ1 caused airway dilation and de-
creased the density of mesenchymal cells (Figure 2C).
Next, we applied IQ1 to lung organ culture to confirm
that the disruption of branching in utero did not result
from overall poor general condition of the embryos, as
we have previously demonstrated that IQ1 also affects
cardiac and vascular system development [13]. We cultured
E12.5 lung explants at a gas–liquid interface on membrane
filters for 24 hours. We examined the effects of both the
specific small molecule β-catenin/CBP inhibitor ICG-001,
as well as the β-catenin/p300 inhibitor IQ1 in this model.
We found that inhibition of the β-catenin/p300 interaction
with IQ1, but not the β-catenin/CBP interaction with
ICG-001, significantly decreased the number of distal
tips at 24 hours ex vivo (Figure 2D and 2E). The differ-
ences are even more striking after two days of culture
(Figure 3A). ICG-001 slightly slowed the growth of
explants, however we observed new formation of distal
tips in ICG-001 treated but not in IQ1 treated cultures
(Figure 2D and 3A). The effects of differential coactivator
modulation in lung organ culture confirmed that the dis-
ruption of branching morphogenesis in utero was a direct
effect on the lung and did not result from overall inhib-
ition of embryonic development. Our results suggest that
the β-catenin/p300 interaction plays a critical role during
mouse lung branching morphogenesis.
Inhibition of β-catenin/p300 interaction proximalizes the
lung epithelium
The elongated proximal airways observed in the IQ1
treated lungs led us to investigate the hypothesis that
specific inhibition of the β-catenin/p300 interaction
proximalizes the lung epithelium. To test this hypothesis,
we analyzed the expression of both distal and proximal
genes in lung explants by quantitative PCR (qPCR). We
selected Bmp4, Fgf10 and Nkx2-1 (Ttf-1) as distal marker
genes and Sox2 and Scgb1a1 (CC10) as proximal marker
genes. The critical growth factors involved in branching
morphogenesis (Bmp4, Fgf10, Shh) were examined at 6 hours
and 24 h. As anticipated, IQ1 significantly decreased the
expression of the distal genes, Bmp4, Fgf10 and Nkx2-1
(Figure 4A). In addition, whole mount in situ hybridization
confirmed the decrease of the distal genes Bmp4 and
Nkx2-1 expressed in the distal epithelium (Figure 4B).
At same time, IQ1 significantly increased the expression
of the proximal genes, Sox2 and Scgb1a1 (Figure 4A).
However, IQ1 did not decrease the expression of the
widely expressed lung epithelial marker Shh, suggesting
that IQ1 did not disrupt the overall growth of the lung
epithelium (Figure 4A). Our results indicate that IQ1decreased the expression of distal genes and increased the
expression of proximal genes in the lung explants consist-
ent with the hypothesis that inhibition of the β-catenin/
p300 interaction proximalizes lung epithelium.
Proximalizations of the embryonic lung selective via
inhibition of the β-catenin/p300 interaction or β-catenin
deletion are mechanistically distinct
The proximalization resulting from IQ1 inhibition of the
β-catenin/p300 interaction phenotypically resembles those
seen utilizing genetic deletion of β-catenin [6,14]. There-
fore, we decided to compare in detail the mechanisms
involved in the pharmacologic inhibition of the β-catenin/
p300 interaction to the genetic deletion of β-catenin.
β-catenin interacts with many additional transcription
partners beyond p300 and CBP. Amongst these, the
TCF/LEF family of transcription factors has been most
extensively investigated, as consensus LEF1/TCF-DNA
Figure 4 Gene expression analyses of IQ1 treated lung explants. (A) Quantitative PCR (qPCR) analysis of the lung explants. Lung explants
were cultured with either DMSO (control), IQ1 (10 μM) or ICG-001 (10 μM) for 6 hours or 24 hours. Relative expression changes compared to
E12.5 lungs without culture (0 h) are presented. IQ1 decreased the expression of Bmp4 significantly at 6 hours and 24 hours. IQ1 increased the
expression of Sox2 and Scgb1a1. Explants groups: 6 hours treatment (0 h, n = 8, DMSO n = 8, IQ1, n = 9, ICG-001, n = 3), 24 hours treatment
(0 h, n = 6, DMSO, n = 6, IQ1, n = 6, ICG-001, n = 6). Data are presented as mean ± SD. *p < 0.05 vs. control by t-test. (B) Whole mount in situ
hybridization shows local expression of Bmp4 and Nkx2-1 in the distal epithelium. IQ1 decreased the expression of Bmp4 and Nkx2-1 at 24 hours.
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genes as well as commonly used Wnt signaling reporters.
TOPGAL transgenic mice express β-galactosidase under
the control of canonical Wnt TCF/β-catenin transcription.
To evaluate the effects of specific inhibition of the
β-catenin/p300 interaction on Wnt signaling in mouse
embryonic lung, we treated lung explants from TOPGAL
reporter mice with IQ1. In the vehicle control treated mice,
we observed activated Wnt/TCF/β-catenin dependent
transcription as judged by β-galactosidase activity at the
bronchial epithelium of the proximal airway (Figure 3A,
DMSO, arrow). Selective inhibition of the β-catenin/p300
interaction with IQ1 did not decrease the β-galactosidase
activity in the proximal airways (Figure 3A, IQ1, arrow),
whereas ICG-001, a known inhibitor of β-catenin/CBP
interaction, decreased the proximal β-galactosidase
activity (Figure 3A, ICG-001, arrow). These results demon-
strate that whereas genetic deletion of β-catenin decreases
overall Wnt/TCF/β-catenin dependent signaling, on the
contrary, selective inhibition of the β-catenin/p300
interaction by IQ1 maintains rather than decreases
Wnt/β-catenin/TCF dependent reporter activity in the
proximal airways. Furthermore, selective inhibition of
the β-catenin/CBP interaction decreases proximal butnot distal Wnt/β-catenin/TCF dependent activity without
apparently affecting normal lung development ex vivo.
β-catenin is a multifunctional protein that beyond its
role as a transcriptional activator of Wnt signaling, is also
an important protein component of adherens junction,
which are important for epithelial cell-cell adhesion. To test
if the inhibition of the β-catenin/p300 interaction affected
the expression and localization of β-catenin in the lung
epithelium, we next examined β-catenin by immunohis-
tochemistry. We found β-catenin widely expressed in
both the epithelium and mesenchyme of the control treated
lungs (Figure 3B). Localization of β-catenin at the epithelial
cell membrane (Figure 3B, arrows) is consistent with its
important role in cell-cell adhesion in the lung epithelium.
However, inhibition of the β-catenin/p300 interaction
by IQ1 did not change the expression or localization of
β-catenin whereas deletion of β-catenin completely
eliminates it.
Genetic deletion of β-catenin also causes a disruption
in angiogenesis of peripheral vessels [6]. To examine if
inhibition of the β-catenin/p300 interaction disrupted
angiogenesis of peripheral vessels, we immunostained
whole mount lungs with an antibody specific for the
endothelial cell marker PECAM-1. Compared to the vehicle
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capillary endothelium surrounding the distal tips of the IQ1
treated lungs (Figure 3C). This result suggests that IQ1 did
not dramatically disrupt angiogenesis of peripheral capillary
vessels whereas genetic deletion of β-catenin does.
Based on these experiments, we suggest that although
phenotypically similar, the inhibitions of branching
morphogenesis via selective pharmacological inhibition
of the β-catenin/p300 interaction or genetic deletion of
β-catenin are mechanistically distinct.
Inhibition of the β-catenin/p300 interaction and branching
morphogenesis by IQ1 is reversible
Finally, we addressed the question of whether or not
inhibition of branching morphogenesis by IQ1 disrup-
tion of the β-catenin/p300 interaction is reversible. To
examine this question, we first cultured lung explants
with IQ1 for 48 hours and either maintained the treat-
ment with IQ1 or removed the IQ1 from the culture
media. After an additional 48 hours of ex vivo culture
conditions without IQ1, new branching at the distal
tips was observed, whereas in the presence of IQ1, dis-
tal branching was still absent as anticipated (Figure 5A).
Similarly, we treated E12.5 mouse embryos in utero for
one day and then stopped IQ1 feeding to the pregnant
mothers for an additional two days. In the lungs transi-
ently treated with IQ1, we found distal branching tips,
essentially equivalent to the untreated controls, although
the overall lung lobe was smaller, presumably due to the
temporary delay in development (Figure 5B). By immuno-
histochemistry of alpha smooth muscle actin (α-SMA),
a marker of myofibroblasts, we observed myofibroblastsFigure 5 Branching restarts on removal of IQ1. (A) E13.5 lung explants
removed from the culture media. After two days of the additional culture w
(B) E11.5 embryos were treated with IQ1 in utero for one day. The embryos
absence of IQ1. ALP staining of the left lobe shows fine branching equivale
were cultured with either DMSO (control) or IQ1 (10 μM) for 24 hours. Imm
proximal airway. However, myofibroblasts are absent at the distal tips in bo
stained with hematoxylin.surrounding the proximal airway but not the distal epi-
thelial tips in both the control and IQ1 treated lungs
(Figure 5C). The absence of myofibroblasts at the distal
tips of the IQ1 treated lungs implies that the distal tips
maintain their distal properties and maintain the plasticity
to undergo branching morphogenesis upon removal of
the inhibitory effects of IQ1. We further speculate that
this plasticity, under continuous IQ1 treatment fosters
the elongation of the epithelial tubes without branching
(Figure 2A). These results suggest that β-catenin/p300
inhibition by IQ1 transiently disrupts lung branching
morphogenesis but maintains the plasticity of the epithelial
cells at the distal tips for at least 24 hours.
Discussion
Wnt/β-catenin signaling is critical during multiple stages
of lung development [5]. Based upon genetically modified
mouse models, Wnt/β-catenin signaling has also been im-
plicated in the regulation of the proximal-distal axis during
embryonic lung development. We now provide evidence
that interaction between β-catenin and specifically the Kat3
coactivator p300 plays a critical role in proximal-distal axis
determination during epithelial lung branching morpho-
genesis. Inhibition of the β-catenin/p300 interaction, using
the previously characterized small molecule inhibitor IQ1
[7] disrupted distal branching of murine lung epithelium in
utero (Figure 2A) and ex vivo (Figure 2D). The phenotype
of the IQ1 treated lungs involved proximalization as judged
by decreased expression of the distal genes Bmp4, Nkx2-1
(Ttf-1) and Fgf10 and increased expression of the proximal
genes and Sox2 and Scgb1a1 (CC10) (Figure 4A). Bmp4
and Nkx2-1 are expressed in the distal epithelium,were cultured with IQ1 for 48 hours. Subsequently, the IQ1 was
ithout IQ1, new branching ends were found at the distal tips (arrows).
were subsequently dissected at E14.5 after two days of growth in the
nt to the control although the lobe is smaller. (C) E13.5 lung explants
unohistochemistry of α-SMA shows myofibroblasts surrounding the
th the control and IQ1 treated lung explants (arrows). Nuclei were
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On the other hand, Sox2 is expressed in the proximal
epithelium [15] and Scgb1a1 is a proximal secretory
cell marker, expressed primarily in Clara cells [16]. This
proximalization that is induced by specific inhibition
of β-catenin/p300 dependent transcription extends our
understanding and is fully consistent with previous reports
of genetic deletion of β-catenin in the lung epithelium
and inhibition of Wnt signaling via Dkk-1 overexpres-
sion inhibiting branching lung morphogenesis [6,14,17].
These earlier investigations in conjunction with our
current study, confirm that β-catenin and in particular
its interaction with the transcriptional coactivator p300
is critical for proximal-distal determination during lung
branching morphogenesis. Our chemical genomic approach
that selectively inhibits only a subset of the transcriptional
roles of β-catenin, without interfering with its role in adhe-
rens complexes at the cell membrane, provides convincing
evidence that transcriptional function of β-catenin, not
the cell-cell adhesion function is critical for proximal-
distal determination. Interestingly, Shikama et al. had
previously demonstrated that embryonic mice with even a
single allele carrying a defective p300 Histone acetyltrans-
ferase (HAT) domain die at birth due to respiratory failure,
whereas CBP HAT defective embryos did not demonstrate
major lung developmental defects [18]. This is consistent
with our results that demonstrate that specific disrup-
tion of the β-catenin/p300 dramatically inhibits branch-
ing lung morphogenesis, although the phenotypes
induced by IQ1 specifically blocking the β-catenin/p300
interaction and knock-in of defective p300 HAT activity
do diverge in other respects.
We propose that one of the primary mechanisms by
which inhibition of the β-catenin/p300 interaction in-
duces lung proximalization involves the downregula-
tion of Bmp4 and Fgf10 expression. Bmp4 and Fgf10
are both essential growth factors in lung branching
morphogenesis to induce the growth of distal tips [19].
Formation of the distal respiratory epithelium and
branching of the proximal airways requires BMP4, which
is expressed at the tip of elongating epithelial buds [20].
Inhibition of BMP signaling in utero by overexpression
of Noggin resulted in lung proximalization [20]. Fgf10 is
expressed in the lung mesenchyme and reductions in
Fgf10 expression result in compaction of terminal sac-
cules and neonatal lethality [21,22]. In our study, inhib-
ition of the β-catenin/p300 interaction decreased the
expression of both Bmp4 and Fgf10 in the lung explants
(Figure 4A). The downregulation of Bmp4 expression
was significant already at 6 hours after IQ1 treatment,
consistent with BMP4 being a direct Wnt/β-catenin
target gene [23]. FGF10 expression although essentially
unchanged at 6 hours, was significantly decreased at
24 hours consistent with it being Wnt regulated in thedistal lung mesenchyme in an indirect fashion [24]. Our
qPCR and in situ hybridization data suggest that expression
of both Bmp4 and Fgf10 is dependent on β-catenin/p300
transcription. Consistent with our results, both Bmp4
and Fgf10 have been previously identified as downstream
Wnt/β-catenin target genes during proximal-distal pattern-
ing in the lung [14,25]. Our result correspondingly indicates
that β-catenin/p300 transcription regulates the expression
of Bmp4 and Fgf10 during lung development. Interestingly,
inhibition of the corresponding β-catenin/CBP inter-
action with ICG-001 did not disrupt branching signifi-
cantly ex vivo (Figure 2E and 3A) and did not affect
normal lung development in utero (Figure 2B). The sig-
nificant differences between the effects of the specific
small molecule coactivator modulators IQ1 and ICG-001
further demonstrates that Wnt/β-catenin regulated gene
transcription is dramatically dependent on its choice
amongst the two coactivators, p300 and CBP and that
the β-catenin/p300 interaction is essential during lung
branching morphogenesis. This result is again fully con-
sistent with the previous results of Shikama et al. [18].
Activation of the Wnt/β-catenin signaling cascade is
critical during lung development and has been impli-
cated in the restoration of normal tissue structure and
function, as well as remodeling/fibrosis in a number of
organs, including the lung, suggesting that this devel-
opmental pathway can be reactivated in adult tissues
following injury [26,27]. However, exquisite control over
reactivation of these developmental pathways is critical,
as aberrant activation is associated with lung disease in-
cluding asthma and fibrosis [28,29]. Therefore, a precise
understanding of the role of differential coactivator usage
in the Wnt/β-catenin pathway during development and
repair after injury is important. In particular, the ability
to safely therapeutically modulate coactivator usage has
a number of clinical ramifications [30]. We previously
demonstrated that administration of the CBP/β-catenin
antagonist ICG-001 prevents and reverses established
lung fibrosis and dramatically improves animal survival
[2]. Similar results have been demonstrated in experi-
mental models of kidney fibrosis [31], and acute lung
injury [32]. Impaired branching of the alveolar tree in
genetically modified mice leads to respiratory failure
resulting from decreased surface for gas exchange.
Overall, the lung phenotype bears similarity to respira-
tory distress syndrome and bronchopulmonary dyspla-
sia, the most common complications of prematurity in
humans [33]. Based upon our previous results and the
results of our current study, we propose that CBP/catenin
antagonists could be safely utilized to treat respiratory
distress syndrome and bronchopulmonary dysplasia in
infants. In this regard, the recently developed second
generation specific Wnt/CBP/catenin antagonist PRI-
724 (IC50 ~ 150 nM) has proven extremely safe in both
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studies and in a Phase Ia clinical trial [34]. In regards to re-
generative medicine, ex vivo small molecule modulation of
stem and progenitors cells offers another avenue to pursue.
In that regard, Banerjee et al. demonstrated that human
embryonic stem cells (hES cells) directed to alveolar type II
(ATII) lung progenitor cells, could be differentiated into
an alveolar type I (ATI) phenotype following incubation
with the CBP/β-catenin antagonist ICG-001 [35]. One
week after acute lung injury induced by bleomycin ad-
ministration, these differentiated hES cells were able to
home to the small airways and engraft, with an accompan-
ied marked reduction in collagen deposition and tissue
damage. In the future, the potential to construct bioartificial
lungs could provide a source for organs for transplantation.
Bioartificial lungs would provide a mechanism to circum-
vent the problems of donor shortage and immunogenicity.
Unlike decellularized lung, synthetic bioartificial scaffolds
lack the endogenous growth factors that are required to
signal the seeded progenitor cells to essentially recapitu-
late ex vivo the lung development process [36]. Small
molecule manipulation of signaling pathways may be
used to guide proximal–distal patterning of lung pro-
genitor cells seeded on a synthetic bioartificial scaffold.
Conclusions
Our study provides strong evidence that the interaction
between β-catenin and p300 is critically important in
proximal-distal axis determination during mouse lung
branching morphogenesis. Our results are consistent and
add further refinement to multiple previous reports regard-
ing the role of β-catenin on proximal-distal determination
in the lung based upon genetic deletion of β-catenin as well
as previous reports on the differential roles of the coactiva-
tors CBP and p300 during lung development. The chemical
genomic approach utilized herein further elucidated and
clarified the specific role of the coactivator p300 in the
regulation of Wnt/β-catenin driven branching morphogen-
esis in the lung. This information, along with the ability to
safely pharmacologically manipulate differential coactivator
usage in the Wnt/β-catenin cascade provides multiple
therapeutic opportunities to investigate going forward.
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